Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2003
02/20/2003WO2002077264A3 Arrayed transfection method and uses related thereto
02/20/2003WO2002074433A3 Method and devices for applying reagents to punctiform locations
02/20/2003WO2002073158A3 Conjugate probes and optical detection of analytes
02/20/2003WO2002072871A3 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes
02/20/2003WO2002072866A3 Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma
02/20/2003WO2002068645A8 Compositions and methods relating to breast specific genes and proteins
02/20/2003WO2002068605A3 Non-oligomerizing tandem fluorescent proteins
02/20/2003WO2002067860A3 Selection by mirror image display
02/20/2003WO2002064758A9 An optical method for testing sensitivity of cells
02/20/2003WO2002064556A3 Complex carbohydrate arrays and methods for the manufacture and uses thereof
02/20/2003WO2002062821A3 Peptide or protein microassay method and apparatus
02/20/2003WO2002058637A3 Compositions and methods for diagnosis of neuropsychiatric disorders
02/20/2003WO2002057307A3 Genes
02/20/2003WO2002052012A8 Sugar beet genes involved in stress tolerance
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003WO2002044733A3 Methods and compositions for sorting and/or determining microorganisms
02/20/2003WO2002044335A3 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
02/20/2003WO2002033120B1 Non-invasive prenatal monitoring
02/20/2003WO2002029088A9 Highly expressible genes
02/20/2003WO2002026950A3 Transferases
02/20/2003WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
02/20/2003WO2002023187A9 Facile detection of cancer and cancer risk based on level of coordination between alleles
02/20/2003WO2002022889A9 Direct haplotyping using carbon nanotube probes
02/20/2003WO2002022783A8 Liver gene expression associated with the inhibition of hbv replication or transcription
02/20/2003WO2002014857B1 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
02/20/2003WO2002014368A8 Proteins and nucleic acids encoding the same
02/20/2003WO2002007780A3 Methods for identifying therapeutic targets
02/20/2003WO2001073109A3 Continuous process for manufacture of disposable electro-chemical sensor
02/20/2003WO2001064949A9 Diagnostics and therapeutics for glaucoma
02/20/2003WO2001057271A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells
02/20/2003WO2001053538A3 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
02/20/2003WO2001047944A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
02/20/2003US20030037354 Animal model for use in the diagnosis and treatment of nervous system disorders
02/20/2003US20030037350 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of cancer and nervous system disorders
02/20/2003US20030037345 Compositions and methods for wound healing
02/20/2003US20030036857 Methods and systems of biomolecular sequence matching
02/20/2003US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies
02/20/2003US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it
02/20/2003US20030036642 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
02/20/2003US20030036633 DNA encoding bradykinin B1 receptor
02/20/2003US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects
02/20/2003US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics
02/20/2003US20030036533 Used in infections by viruses, bacteria, fungi, and parasites
02/20/2003US20030036526 Activating a signaling cascade comprising, introducing leptin and/or a cytokine to a receptor complex comprising gp 130, to genes in neuro- endocrine cells or cells of neuro-endocrine origin.
02/20/2003US20030036522 Pluripotent cells suitable for transplantation therapy, to repair neural damage, are identified, e.g. by differential display, from a gene expression profile for a selected cell, which can be compared with that obtained from a control cell
02/20/2003US20030036521 Also using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues.
02/20/2003US20030036517 Identifying accessible regions in a target RNA molecule using trans-splicing nucleic acid molecules
02/20/2003US20030036507 Urocortin-III and uses thereof
02/20/2003US20030036505 Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon
02/20/2003US20030036208 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
02/20/2003US20030036199 Kit for use in the diagnosis and treatment of cancer
02/20/2003US20030036197 Recombinant constructs and their use in reducing gene expression
02/20/2003US20030036194 Genetically engineered cell for use in regenerative medicine
02/20/2003US20030036186 Process for the preparation of cell beads BOD sensor useful for instant BOD estimation
02/20/2003US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides
02/20/2003US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity
02/20/2003US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders
02/20/2003US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036178 Long wavelength engineered fluorescent proteins
02/20/2003US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
02/20/2003US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production.
02/20/2003US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders
02/20/2003US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders
02/20/2003US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036116 Can be used in combination with other mutagenesis methods
02/20/2003US20030036115 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM6, expressed highly in the small intestine
02/20/2003US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
02/20/2003US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins
02/20/2003US20030036109 Detection of bacteria in liquid sample; obtain sample, incubate with substrate, stain, evaluate substrate for presence of bacteria, presence of stained areas indicates presence of bacteria
02/20/2003US20030036108 Detection of cell fusion; obtain cells, measure fluorescence resonance energy transfer, compare to control and evaluate fusion
02/20/2003US20030036103 Methods and compositions for diagnosis and treatment of vascular conditions
02/20/2003US20030036096 Chemical-library composition and method
02/20/2003US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders
02/20/2003US20030036088 Separation of viruses in sample; obtain sample containing viruses, incubate with filter, recover and analyze preferential virus from filter
02/20/2003US20030036084 Nucleic acid detection method employing oligonucleotide probes affixed to particles and related compositions
02/20/2003US20030036082 Screening methods
02/20/2003US20030036081 Distributed system for epigenetic based prediction of complex phenotypes
02/20/2003US20030036080 Detecting preferential fluorescent biopolymers in sample; obtain sample, insert into analytical apparatus, detect signal for samples, record fluorescence times, designate fluorescent species
02/20/2003US20030036079 Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
02/20/2003US20030036078 P5CRs as modifiers of the p53 pathway and methods of use
02/20/2003US20030036077 Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers
02/20/2003US20030036076 CADs as modifiers of the p53 pathway and methods of use
02/20/2003US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders
02/20/2003US20030036073 Matrix Sequencing: a novel method of polynucleotide analysis utilizing probes containing universal nucleotides
02/20/2003US20030036072 Detection of preferential nucleotide sequences in sample; obtain nucleic acids, incubate with probes, detect signal from sample
02/20/2003US20030036071 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression
02/20/2003US20030036070 Gene expression profiling of inflammatory bowel disease
02/20/2003US20030036069 Complexity Managment of genomic DNA
02/20/2003US20030036068 Diagnosis and detection of cancer; obtain tissue sample, extract nucleotide sequences, incubate with probe preferential for tumor sequences, detect binding, bound probe indicates tumors
02/20/2003US20030036067 Image processing and analysis of individual nucleic acid molecules
02/20/2003US20030036065 Generation of probe; obtain target nucleotide sequences, incubate with primer, fuse primer to nucleotide sequences, recover probes
02/20/2003US20030036064 Compositions and methods for repetitive use of genomic DNA
02/20/2003US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders
02/20/2003US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same